Skip to main content
SURAKSHA DIAGNOSTIC LIMITED logo

SURAKSHA DIAGNOSTIC LIMITED — Investor Relations & Filings

Ticker · SURAKSHA ISIN · INE877V01027 LEI · 335800SJSOH7ZQHTPO56 BSE.NS Human health and social work activities
Open in API
Filings indexed 144 across all filing types
Latest filing 2025-08-14 Call Transcript
Country IN India
Listing BSE.NS SURAKSHA

About SURAKSHA DIAGNOSTIC LIMITED

https://www.surakshanet.com

Suraksha Diagnostic Limited is a prominent diagnostic healthcare service provider primarily operating in Eastern India. The company offers a comprehensive range of pathology and radiology services, including clinical laboratory tests, molecular diagnostics, and advanced imaging such as MRI, CT scans, ultrasound, and X-rays. It operates a network of diagnostic centers and polyclinics, providing integrated healthcare solutions that encompass specialized consultations and preventive health check-ups. The organization is recognized for its commitment to quality, maintaining international standards through NABL and CAP accreditations. By leveraging advanced medical technology and a robust logistics framework for home collection, the company serves a diverse patient base, focusing on accurate clinical outcomes and accessible diagnostic care.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on August 11, 2025, discussing the financial results for the quarter ended June 30, 2025 (Q1 FY26). It includes management commentary on operational updates, financial performance metrics such as total income, EBITDA, and PAT, and a Q&A session with analysts. The document references unaudited standalone and consolidated financial results and provides forward-looking statements and strategic updates. The presence of a full transcript of the call, including moderator and participant dialogue, confirms this is a Call Transcript (CT) rather than a brief earnings release or investor presentation. The document length (15,000 characters) and content depth support this classification.
2025-08-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of an earnings call held on 11 August 2025. It references the unaudited financial results for the quarter ended 30 June 2025 and provides a link to the audio recording on the company's website. The document is short (2112 characters) and serves as an announcement or intimation about the earnings call audio recording rather than containing the transcript or detailed financial data itself. Therefore, it is not the earnings release or call transcript but an announcement related to the earnings call. Given the nature of the document as an intimation or disclosure under SEBI regulations about the earnings call audio recording, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure.
2025-08-11 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is dated 09 August 2025 and is addressed to stock exchanges (BSE and NSE) with a subject indicating a presentation to be made at an Analyst/Investor Meet or Earnings Call. It includes an investor presentation on unaudited quarterly financial results for the quarter ended 30 June 2025 (Q1 FY26). The content includes detailed financial performance metrics, operational highlights, strategic acquisitions, and future growth plans. The document is lengthy (15,000 characters) and contains substantive financial data and analysis for a quarter, not just a brief announcement or a link to a report. The presence of detailed financial tables, performance metrics, and strategic information aligns with the characteristics of an Investor Presentation. It is not a full Annual Report, Audit Report, or Earnings Release (which typically are shorter and more focused on headline results). It is also not a Call Transcript, as it does not contain Q&A or verbatim call text. Therefore, the document best fits the category of Investor Presentation (IP).
2025-08-09 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter dated 09 August 2025 from Suraksha Diagnostic Limited addressed to stock exchanges (BSE and NSE). It informs about the completion of dispatch of the Annual Report for FY 2024-25 including the Notice of the 20th Annual General Meeting (AGM). The letter mentions that the Annual Report and Notice have been sent electronically to members and that newspaper advertisements have been published detailing the e-voting procedure for the upcoming AGM scheduled for 05 September 2025. The document does not contain the Annual Report itself but is an announcement regarding the dispatch and availability of the Annual Report and AGM Notice. The document length is 15,000 characters, but the content is primarily an announcement and not the full report. According to the "Menu vs Meal" rule, such a document is classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K).
2025-08-09 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains multiple distinct sections. The first part is a letter addressed to stock exchanges regarding the newspaper publication of unaudited standalone and consolidated financial results for the quarter ended 30 June 2025, which is a typical disclosure under SEBI regulations. The document includes extracts of unaudited consolidated financial results for the quarter ended 30 June 2025, with detailed financial figures such as total income, net profit before and after tax, earnings per share, and other financial ratios. The presence of detailed financial data for a quarter, including comparative figures for the previous quarter and year, indicates this is a quarterly financial report. The document also references Regulation 33 and 52 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which govern quarterly financial results disclosures. The length of the document (15,000 characters) and the inclusion of substantive financial data confirm it is not merely an announcement or a certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2026
2025-08-09 English
ESOP/ESOS/ESPS
Capital/Financing Update Classification · 95% confidence The document is an official communication from Suraksha Diagnostic Limited to stock exchanges (BSE and NSE) regarding the grant of Employee Stock Options (ESOP) under the 'SURAKSHA EMPLOYEE STOCK OPTION SCHEME 2024'. It references compliance with SEBI Listing Regulations and provides detailed disclosure under Regulation 30 of SEBI Listing Regulations, including specifics about the number of options granted, pricing, vesting schedule, and other terms. The document is an announcement of a corporate action related to employee stock options, specifically the grant of options, not a full report or financial statement. It does not contain financial results, audit opinions, or management discussion and analysis. It is a regulatory disclosure about a capital/financing activity (grant of stock options). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is over 10,000 characters and contains detailed information, so it is not a mere announcement of a report (RPA) or a regulatory filing (RNS).
2025-08-08 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.